Literature DB >> 10926172

Is aplastic osteodystrophy a disease of malnutrition?

M Fukagawa1, T Akizawa, K Kurokawa.   

Abstract

Adynamic bone disease is emerging as a major type of renal osteodystrophy in chronic dialysis patients. Relative hypoparathyroidism is one of the important abnormalities underlying this disease. Recently, several reports have suggested that hypoparathyroidism reflects, at least in part, a state of malnutrition and contributes to the poor prognosis of patients on hemodialysis and chronic ambulatory peritoneal dialysis. Such a risk of survival may result not only from the malnutritional state, but also from unknown mechanisms resulting from parathyroid hormone (PTH) deficiency, or from other abnormalities that suppress PTH secretion. Another major abnormality underlying adynamic bone disease is the skeletal resistance to PTH in patients with uremia. Owing to the recent research on bone turnover at the molecular level, several new mechanisms for this abnormality have been elucidated. Correction of this 'skeletal resistance to PTH' will lead to the optimal management of parathyroid function and bone turnover in the future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926172     DOI: 10.1097/00041552-200007000-00007

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

Review 1.  Diseases of the parathyroid gland in chronic kidney disease.

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

Review 2.  Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients.

Authors:  Usama Feroze; Miklos Z Molnar; Ramanath Dukkipati; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2011-01       Impact factor: 3.655

3.  Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.

Authors:  Ramanath Dukkipati; Csaba P Kovesdy; Sara Colman; Matthew J Budoff; Allen R Nissenson; Stuart M Sprague; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2010-03-03       Impact factor: 3.655

4.  Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.

Authors:  Yen-Chung Lin; Yi-Chun Lin; Chiao-Ying Hsu; Chih-Chin Kao; Fan-Chi Chang; Tzen-Wen Chen; Hsi-Hsien Chen; Chi-Cheng Hsu; Mai-Szu Wu
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

5.  Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: a prospective cohort study.

Authors:  Yu Ah Hong; Jeong Ho Kim; Yong Kyun Kim; Yoon Kyung Chang; Cheol Whee Park; Suk Young Kim; Yon Su Kim; Shin-Wook Kang; Nam-Ho Kim; Yong-Lim Kim; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2019-10-28       Impact factor: 2.884

6.  Low serum parathyroid hormone is a risk factor for peritonitis episodes in incident peritoneal dialysis patients: a retrospective study.

Authors:  Yuqi Yang; Jingjing Da; Yi Jiang; Jing Yuan; Yan Zha
Journal:  BMC Nephrol       Date:  2021-01-29       Impact factor: 2.388

7.  Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients.

Authors:  Guillaume Jean; Jean-Claude Souberbielle; Eric Zaoui; Christie Lorriaux; Jean-Marc Hurot; Brice Mayor; Patrik Deleaval; Manolie Mehdi; Charles Chazot
Journal:  BMC Nephrol       Date:  2016-10-18       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.